These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21390018)

  • 21. How to ensure our readers' trust: the proper attribution of authors and contributors.
    Liesegang TJ; Albert DM; Schachat AP
    Am J Ophthalmol; 2008 Sep; 146(3):337-40. PubMed ID: 18724976
    [No Abstract]   [Full Text] [Related]  

  • 22. Out in the open.
    Nat Biotechnol; 2005 Feb; 23(2):153. PubMed ID: 15696130
    [No Abstract]   [Full Text] [Related]  

  • 23. Justices expand rights to experiment with patented drugs.
    Pollack A
    N Y Times Web; 2005 Jun; ():C1, C8. PubMed ID: 15966121
    [No Abstract]   [Full Text] [Related]  

  • 24. Health hazard labeling for hazard communication in the pharmaceutical industry.
    Sussman RG; Kimmel TA; Neske FW
    Occup Med; 1997; 12(1):107-17. PubMed ID: 9153056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biotechnology products and university-based science.
    Sobolski GK
    JAMA; 2005 Jun; 293(23):2862; author reply 2863. PubMed ID: 15956629
    [No Abstract]   [Full Text] [Related]  

  • 26. Food and Drug Administration public hearing on the draft guidance for exception from informed consent requirements for emergency research: testimony of Novo Nordisk.
    Weiskopf RB;
    Acad Emerg Med; 2007 Apr; 14(4):e71-3. PubMed ID: 17322571
    [No Abstract]   [Full Text] [Related]  

  • 27. University-based science and biotechnology products: defining the boundaries of intellectual property.
    Kesselheim AS; Avorn J
    JAMA; 2005 Feb; 293(7):850-4. PubMed ID: 15713775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biotechnology products and university-based science.
    Korn D; Heinig SJ
    JAMA; 2005 Jun; 293(23):2862-3; author reply 2863. PubMed ID: 15956628
    [No Abstract]   [Full Text] [Related]  

  • 29. Scientific Opinion on Risk Assessment of Synthetic Biology.
    Epstein MM; Vermeire T
    Trends Biotechnol; 2016 Aug; 34(8):601-603. PubMed ID: 27234301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The distortion of commercial research reported in the peer-reviewed literature.
    Liesegang TJ
    Can J Ophthalmol; 2009 Aug; 44(4):367-9. PubMed ID: 19606153
    [No Abstract]   [Full Text] [Related]  

  • 31. AAFP supports improvement, not ban, on direct-to-consumer prescription drug ads.
    Kellerman R;
    Ann Fam Med; 2007; 5(2):180-1. PubMed ID: 17389544
    [No Abstract]   [Full Text] [Related]  

  • 32. Staying sober about science.
    Carlson R
    Hastings Cent Rep; 2011; 41(4):22-5. PubMed ID: 21845918
    [No Abstract]   [Full Text] [Related]  

  • 33. Protection for manufacturing, not research.
    Nat Rev Drug Discov; 2003 Oct; 2(10):766. PubMed ID: 14579809
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmaceutical GMPs.
    Bobrowicz G
    Qual Assur; 1994 Jun; 3(2):138-48. PubMed ID: 7804629
    [No Abstract]   [Full Text] [Related]  

  • 35. Marketing off-label uses to physicians: FDA's draft (mis)guidance.
    Gass A; Wilson J
    Am J Bioeth; 2008 Mar; 8(3):1-3. PubMed ID: 18570084
    [No Abstract]   [Full Text] [Related]  

  • 36. Plans for research watchdog praised, but it may lack teeth.
    Giles J
    Nature; 2005 Mar; 434(7031):263. PubMed ID: 15772618
    [No Abstract]   [Full Text] [Related]  

  • 37. "Obvious to try": a proper patentability standard in the pharmaceutical arts?
    Trask AV
    Fordham Law Rev; 2008 Apr; 76(5):2625-68. PubMed ID: 18546581
    [No Abstract]   [Full Text] [Related]  

  • 38. Conflict of interest. Stung by controversy, biomedical groups urge consistent guidelines.
    Kaiser J
    Science; 2007 Jul; 317(5837):441. PubMed ID: 17656694
    [No Abstract]   [Full Text] [Related]  

  • 39. Context, existing frameworks, and practicality: moving forward with synthetic biology.
    Carter SR
    Hastings Cent Rep; 2014; 44(6 Spec no.):S46-8. PubMed ID: 25418707
    [No Abstract]   [Full Text] [Related]  

  • 40. The EPA's new chemicals program under TSCA.
    Culleen LE
    Qual Assur; 1993; 2(1-2):121-6. PubMed ID: 8156198
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.